Results 261 to 270 of about 5,552,491 (299)

Combining antibody conjugates with cytotoxic and immune‐stimulating payloads maximizes anti‐cancer activity

open access: yesMolecular Oncology, EarlyView.
Methods to improve antibody–drug conjugate (ADC) treatment durability in cancer therapy are needed. We utilized ADCs and immune‐stimulating antibody conjugates (ISACs), which are made from two non‐competitive antibodies, to enhance the entry of toxic payloads into cancer cells and deliver immunostimulatory agents into immune cells.
Tiexin Wang   +3 more
wiley   +1 more source

Dammarenediol II enhances etoposide‐induced apoptosis by targeting O‐GlcNAc transferase and Akt/GSK3β/mTOR signaling in liver cancer

open access: yesMolecular Oncology, EarlyView.
Etoposide induces DNA damage, activating p53‐dependent apoptosis via caspase‐3/7, which cleaves PARP1. Dammarenediol II enhances this apoptotic pathway by suppressing O‐GlcNAc transferase activity, further decreasing O‐GlcNAcylation. The reduction in O‐GlcNAc levels boosts p53‐driven apoptosis and influences the Akt/GSK3β/mTOR signaling pathway ...
Jaehoon Lee   +8 more
wiley   +1 more source

Clinical Implications of Upregulated <i>RSAD2</i> Gene Expression in Hepatocellular Carcinoma. [PDF]

open access: yesDiseases
Li L   +11 more
europepmc   +1 more source

The genetic influence of sex on gene expression for blood in pigs. [PDF]

open access: yesBMC Genomics
Lin Q   +5 more
europepmc   +1 more source

Two-Color Timestamping of Gene Expression with a Chemigenetic Reporter System. [PDF]

open access: yesChembiochem
Lämmermann H   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy